1.Allergic Rhinitis in Preschool Children and the Clinical Utility of FeNO.
Jisun YOON ; Yean Jung CHOI ; Eun LEE ; Hyun Ju CHO ; Song I YANG ; Young Ho KIM ; Young Ho JUNG ; Ju Hee SEO ; Ji Won KWON ; Hyo Bin KIM ; So Yeon LEE ; Bong Seong KIM ; Jung Yeon SHIM ; Eun Jin KIM ; Joo Shil LEE ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2017;9(4):314-321
PURPOSE: The nature of allergic rhinitis (AR) in preschool aged children remains incompletely characterized. This study aimed to investigate the prevalence of AR and its associated risk factors in preschool-aged children and to assess the clinical utility of fractional exhaled nitric oxide (FeNO). METHODS: This general population-based, cross-sectional survey included 933 preschool-aged (3- to 7-year-old) children from Korea. Current AR was defined as having nasal symptoms within the last 12 months and physician-diagnosed AR. RESULTS: The prevalence of current AR in preschool children was 17.0% (156/919). Mold exposure (adjusted odds ratio [aOR], 1.67; 95% confidence interval [CI], 1.15-2.43) and the use of antibiotics (aOR, 1.97; 95% CI, 1.33-2.90) during infancy were associated with an increased risk of current AR, whereas having an older sibling (aOR, 0.52; 95% CI, 0.35-0.75) reduced the risk. Children with current atopic AR had significantly higher geometric mean levels of FeNO compared to those with non-atopic rhinitis (12.43; range of 1standard deviation [SD], 7.31-21.14 vs 8.25; range of 1SD, 5.62-12.10, P=0.001) or non-atopic healthy children (8.58; range of 1SD, 5.51-13.38, P<0.001). The FeNO levels were higher in children with current atopic AR compared with atopic healthy children (9.78; range of 1SD, 5.97-16.02, P=0.083). CONCLUSIONS: Mold exposure and use of antibiotics during infancy increases the risk of current AR, whereas having an older sibling reduces it. Children with current atopic AR exhibit higher levels of FeNO compared with non-atopic rhinitis cases, suggesting that FeNO levels may be a useful discriminatory marker for subtypes of AR in preschool children.
Anti-Bacterial Agents
;
Child
;
Child, Preschool*
;
Cross-Sectional Studies
;
Fungi
;
Humans
;
Korea
;
Nitric Oxide
;
Odds Ratio
;
Prevalence
;
Rhinitis
;
Rhinitis, Allergic*
;
Risk Factors
;
Siblings
2.Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping.
Sang Won HAN ; Yong Jae KIM ; Seong Hwan AHN ; Woo Keun SEO ; Sungwook YU ; Seung Hun OH ; Hyo Suk NAM ; Hye Yeon CHOI ; Sung Sang YOON ; Seo Hyun KIM ; Jong Yun LEE ; Jun Hong LEE ; Yang Ha HWANG ; Kee Ook LEE ; Yo Han JUNG ; Jun LEE ; Sung Il SOHN ; Youn Nam KIM ; Kyung A LEE ; Cheryl D BUSHNELL ; Kyung Yul LEE
Journal of Stroke 2017;19(3):356-364
BACKGROUND AND PURPOSE: To compare the efficacy and safety of antiplatelet agents for the secondary prevention of ischemic stroke based on cytochrome P450 2C19 (CYP2C19) polymorphisms. METHODS: This study was a prospective, multicenter, randomized, parallel-group, open-label, blind genotype trial. First time non-cardiogenic ischemic stroke patients were enrolled and screened within 30 days. Participants were randomized to receive either triflusal or clopidogrel for secondary stroke prevention. The primary outcome was the time from randomization to first recurrent ischemic stroke or hemorrhagic stroke. RESULTS: The required sample size was 1,080 but only 784 (73%) participants were recruited. In patients with a poor CYP2C19 genotype for clopidogrel metabolism (n=484), the risk of recurrent stroke among those who received triflusal treatment was 2.9% per year, which was not significantly different from those who received clopidogrel treatment (2.2% per year; hazard ratio [HR], 1.23; 95% confidence interval [CI], 0.60–2.53). In the clopidogrel treatment group (n=393), 38% had good genotypes and 62% poor genotypes for clopidogrel metabolism. The risk of recurrent stroke in patients with a good CYP2C19 genotype was 1.6% per year, which was not significantly different from those with a poor genotype (2.2% per year; HR, 0.69; 95% CI, 0.26–1.79). CONCLUSIONS: Whilst there were no significant differences between the treatment groups in the rates of stroke recurrence, major vascular events, or coronary revascularization, the efficacy of antiplatelet agents for the secondary prevention of stroke according to CYP2C19 genotype status remains unclear.
Cytochrome P-450 CYP2C19
;
Cytochrome P-450 Enzyme System*
;
Cytochromes*
;
Genotype
;
Humans
;
Metabolism
;
Platelet Aggregation Inhibitors
;
Prospective Studies
;
Random Allocation
;
Recurrence
;
Sample Size
;
Secondary Prevention*
;
Stroke*
3.Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis.
Su Youn JUN ; Yang Ki SEOK ; Tomoyasu KATO ; Da Som CHUN ; Yoon Hee LEE ; Gun Oh CHONG ; Yoon Soon LEE ; Young Lae CHO ; Dae Gy HONG
Obstetrics & Gynecology Science 2017;60(3):308-313
Intrathoracic metastasis of ovarian cancer has poor prognosis regardless of treatment modality. Recent development of surgical techniques and the new concept of direct infusion of chemotherapeutic agents with hyperthermia could help with the treatment of disseminated diseases in ovarian cancer. Using video-assisted thoracoscopic surgery and intracavitary chemotherapy with hyperthermia, we tried hyperthermic intrathoracic chemotherapy for a case of stage IV high-grade serous ovarian cancer with pleural metastasis. There was no high-grade complication related to the procedure. The patient is alive without disease at 32 months after initial treatment.
Cisplatin*
;
Drug Therapy*
;
Fever
;
Humans
;
Neoplasm Metastasis*
;
Ovarian Neoplasms*
;
Prognosis
;
Thoracic Surgery, Video-Assisted
4.Acute cor pulmonale due to pulmonary tumor thrombotic microangiopathy in two patients with breast cancer.
Sung Young MOON ; Kang Hoon LEE ; Jong Sik LEE ; Hyun Suk YANG ; Hong Ghi LEE ; Yo Han CHO ; So Young YOON
The Korean Journal of Internal Medicine 2017;32(1):190-194
No abstract available.
Breast Neoplasms*
;
Breast*
;
Humans
;
Pulmonary Heart Disease*
;
Thrombotic Microangiopathies*
5.Long-term Results of Modified Salter Innominate Osteotomy for Legg-Calvé-Perthes Disease.
Kyung Soon PARK ; Kyu Jin CHO ; Hong Yeol YANG ; Kamolhuja Eshnazarovich ESHNAZAROV ; Taek Rim YOON
Clinics in Orthopedic Surgery 2017;9(4):397-404
BACKGROUND: In a previous study, we reported clinical and radiographic results of our modified Salter innominate osteotomy technique in 16 hips affected by Legg-Calvé-Perthes disease (LCPD) with an average follow-up of 31.8 months. In this study, we present the long-term results of the osteotomy in LCPD patients followed until physeal closure. METHODS: Thirty hips of 29 patients were followed until skeletal maturation after modified Salter innominate osteotomy. The mean follow-up duration was 12.9 years (range, 9.1 to 16.0 years). Eleven hips (36.7%) were classified as Catterall group III and 19 (63.3%) as Catterall group VI. Stable interposition of a bone block was achieved using one biodegradable screw in nine hips and without any fixation device in 21 hips by simply changing the direction of osteotomy. The Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, and hip function were evaluated at the last follow-up. Radiological outcomes were evaluated using Wiberg's center-edge angle, the Mose method, and Stulberg classification, and osteoarthritic changes were evaluated using the Tonnis classification. RESULTS: Mean HHS and WOMAC score were 80.2 points and 54 points, respectively, preoperatively and these were improved to 96.2 points and 28 points, respectively, at the last follow-up. Clinical results, according to Robinson's criteria, were good in 18, fair in seven, and poor in five hips. Radiological results assessed using the Mose method were good in 18, fair in six, and poor in six hips, and according to the Stulberg classification, nine hips were class I, nine were class II, eight were class III, and four were class IV. The mean center-edge angle improved from 19.7° preoperatively to 29.6° at the final follow-up. According the Tonnis classification, three hips were grade 2, five were grade 1, and 22 were grade 0. Of the three grade 2 hips, two underwent Chiari osteotomy 12.1 and 8.8 years postoperatively, and the other underwent total hip arthroplasty 12.9 years postoperatively. CONCLUSIONS: The modified Salter innominate osteotomy produced relatively satisfactory long-term clinical and radiological results.
Arthroplasty, Replacement, Hip
;
Classification
;
Follow-Up Studies
;
Hip
;
Humans
;
Legg-Calve-Perthes Disease*
;
Methods
;
Ontario
;
Osteoarthritis
;
Osteotomy*
6.Prenatal Maternal Distress and Allergic Diseases in Offspring: Review of Evidence and Possible Pathways.
Dong In SUH ; Hyoung Yoon CHANG ; Eun LEE ; Song I YANG ; Soo Jong HONG
Allergy, Asthma & Immunology Research 2017;9(3):200-211
Recent studies have suggested a close association between prenatal maternal distress and allergic diseases in the offspring. We selected relevant birth-cohort or national registry studies using a keyword search of the PubMed database and summarized current evidence on the impact of prenatal maternal distress on the development of offspring's allergic diseases. Moreover, we postulated possible pathways linking prenatal distress and allergic diseases based on relevant human and animal studies. Both dysregulated hypothalamic-pituitary-adrenal axis and increased oxidative stress may cause structural (altered brain/lung development) and functional (skewed immune development) changes, which may predispose the fetus to developing allergic diseases during childhood. Although many facts are yet to be discovered, changes in the placental response and epigenetic modification are presumed to mediate the whole process from maternal distress to allergic diseases. Maternal prenatal distress can also interact with other physical or environmental factors, including familial or physical factors, indoor and outdoor pollutants, and early childhood psychological distress. The gut-microbiome-brain axis and the role of the microbiome as an immune modulator should be considered when investigating the stress-allergy relationship and exploring potential intervention modalities. Further research is needed, and particular attention should be given to defining the most vulnerable subjects and critical time periods. To this end, studies exploring relevant biomarkers are warranted, which can enable us to explore adequate intervention strategies.
Animals
;
Asthma
;
Biomarkers
;
Epigenomics
;
Fetus
;
Humans
;
Microbiota
;
Oxidative Stress
;
Placenta
7.The First Successful Lung Transplantation in a Korean Child with Cystic Fibrosis.
Soo Ran NOH ; Eun LEE ; Jisun YOON ; Sungsu JUNG ; Song I YANG ; Jinho YU ; Soo Jong HONG
Journal of Korean Medical Science 2017;32(12):2073-2078
Cystic fibrosis (CF) is an autosomal recessive inherited multisystem disorder caused by mutations of the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Respiratory failure remains the most frequent cause of morbidity and mortality. Lung transplantation is the only option to treat end-stage lung disease. Very few cases of CF occur in Koreans. We report the case of a 12-year-old girl with respiratory failure due to CF who underwent lung transplantation. She had been diagnosed with CF 8 years previously after being treated for recurrent Pseudomonas aeruginosa pneumonia and malnutrition based on sweat chloride concentrations and the CFTR protein gene mutation test. Progression to end-stage lung disease and respiratory failure led to registration with the Korean Network for Organ Sharing. She underwent successful double lung transplantation in 2014. Although she has diabetes mellitus and chronic kidney disease, she has a better quality of life and a prolonged life expectancy.
Child*
;
Cystic Fibrosis Transmembrane Conductance Regulator
;
Cystic Fibrosis*
;
Diabetes Mellitus
;
Female
;
Humans
;
Korea
;
Life Expectancy
;
Lung Diseases
;
Lung Transplantation*
;
Lung*
;
Malnutrition
;
Mortality
;
Pneumonia
;
Pseudomonas aeruginosa
;
Quality of Life
;
Renal Insufficiency, Chronic
;
Respiratory Insufficiency
;
Sweat
8.Methylenetetrahydrofolate Reductase Polymorphisms and Risk of Recurrent Pregnancy Loss: a Case-Control Study.
Kyu Ri HWANG ; Young Min CHOI ; Jin Ju KIM ; Sung Ki LEE ; Kwang Moon YANG ; Eun Chan PAIK ; Hyeon Jeong JEONG ; Jong Kwan JUN ; Sang Ho YOON ; Min A HONG
Journal of Korean Medical Science 2017;32(12):2029-2034
The balance between coagulation and fibrinolysis is an essential part in early pregnancy. Mutations in methylenetetrahydrofolate reductase (MTHFR) gene lead to decreased activity of the enzyme and hyperhomocysteinemia, which then induces platelet aggregation by promoting endothelial oxidative damage, possibly resulting in adverse effect on maintenance of pregnancy. We investigated the role of MTHFR single nucleotide polymorphisms (SNPs), C677T and A1298C, in Korean patients with recurrent pregnancy loss (RPL). We conducted a prospective case-control study in the Korean population. Subjects included 302 women with 2 or more consecutive, unexplained, spontaneous miscarriages before 20 weeks of gestation and 315 control women without a history of recurrent miscarriages. The genotyping for C677T and A1298C polymorphisms was performed using the TaqMan assay. Continuous variables were compared using Student's t-test, and χ² test was used to evaluate differences in the genotype distributions between the RPL and the controls. The genotype distribution of both polymorphisms in the RPL group did not differ from those of the controls. For further analysis, if RPL patients were divided according to the numbers of pregnancy losses (≥ 2 and ≥ 3) neither group was significantly different compared with controls. MTHFR gene C677T and A1298C polymorphisms are not associated with idiopathic RPL in Korean women, suggesting that those may not be susceptible allelic variants or be deficient to cause RPL.
Abortion, Habitual
;
Abortion, Spontaneous
;
Case-Control Studies*
;
Female
;
Fibrinolysis
;
Genotype
;
Humans
;
Hyperhomocysteinemia
;
Methylenetetrahydrofolate Reductase (NADPH2)*
;
Platelet Aggregation
;
Polymorphism, Single Nucleotide
;
Pregnancy*
;
Prospective Studies
9.Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Eun Jin HEO ; Young Jae CHO ; William Chi CHO ; Ji Eun HONG ; Hye Kyung JEON ; Doo Yi OH ; Yoon La CHOI ; Sang Yong SONG ; Jung Joo CHOI ; Duk Soo BAE ; Yoo Young LEE ; Chel Hun CHOI ; Tae Joong KIM ; Woong Yang PARK ; Byoung Gie KIM ; Jeong Won LEE
Cancer Research and Treatment 2017;49(4):915-926
PURPOSE: Patient-derived tumor xenografts (PDXs) can provide more reliable information about tumor biology than cell line models. We developed PDXs for epithelial ovarian cancer (EOC) that have histopathologic and genetic similarities to the primary patient tissues and evaluated their potential for use as a platform for translational EOC research. MATERIALS AND METHODS: We successfully established PDXs by subrenal capsule implantation of primary EOC tissues into female BALB/C-nude mice. The rate of successful PDX engraftment was 48.8% (22/45 cases). Hematoxylin and eosin staining and short tandem repeat analysis showed histopathological and genetic similarity between the PDX and primary patient tissues. RESULTS: Patients whose tumors were successfully engrafted in mice had significantly inferior overall survival when compared with those whose tumors failed to engraft (p=0.040). In preclinical tests of this model, we found that paclitaxel-carboplatin combination chemotherapy significantly deceased tumor weight in PDXs compared with the control treatment (p=0.013). Moreover, erlotinib treatment significantly decreased tumor weight in epidermal growth factor receptor–overexpressing PDX with clear cell histology (p=0.023). CONCLUSION: PDXs for EOC with histopathological and genetic stability can be efficiently developed by subrenal capsule implantation and have the potential to provide a promising platform for future translational research and precision medicine for EOC.
Animals
;
Biology
;
Cell Line
;
Drug Therapy, Combination
;
Eosine Yellowish-(YS)
;
Epidermal Growth Factor
;
Erlotinib Hydrochloride
;
Female
;
Hematoxylin
;
Heterografts*
;
Humans
;
Mice
;
Microsatellite Repeats
;
Molecular Targeted Therapy
;
Ovarian Neoplasms*
;
Precision Medicine
;
Translational Medical Research
;
Tumor Burden
10.Aorto-carotid bypass in patients with Takayasu arteritis.
Hong Seok HAN ; Kyoung Won YOON ; Seon Hee HEO ; Yang Jin PARK ; Young Wook KIM ; Dong Ik KIM
Annals of Surgical Treatment and Research 2017;93(3):143-151
PURPOSE: Takayasu arteritis is an indication for bypass surgery when this condition results in severe cerebrovascular ischemia due to occlusion of the carotid arteries. We reviewed the patients with Takayasu arteritis who received aorto-carotid bypass due to cerebrovascular ischemia. METHODS: A retrospective review was performed on 19 patients with Takayasu arteritis who underwent aorto-carotid bypass from March 2002 to April 2015. RESULTS: All patients were female and the mean of their age was 40.6 ± 15.3 years. Eleven patients (57.9%) underwent aorto-uni-carotid bypass and 8 patients (42.1%) underwent aorto-bi-carotid bypass. Five patients (26.3%) whose postoperative blood pressure was not controlled suffered an intracranial hemorrhage within 8 days after bypass surgery. Of the patients with an intracranial hemorrhage, 2 patients (10.5%) expired on 26 days and 7 years after surgery, and 3 patients (15.8%) resolved spontaneously. One patient (5.3%) expired due to an intracranial infarction 9 years after bypass surgery. The intracranial ischemic symptoms resolved after bypass surgery in all of the surviving patients. None of the patients experienced anastomosis site complication postoperatively. CONCLUSION: Aorto-carotid bypass is effective for treating Takayasu arteritis with cerebrovascular ischemia, and the results suggest that postoperative blood pressure should be strictly managed to prevent intracranial hemorrhage.
Blood Pressure
;
Carotid Arteries
;
Female
;
Humans
;
Infarction
;
Intracranial Hemorrhages
;
Ischemia
;
Retrospective Studies
;
Takayasu Arteritis*

Result Analysis
Print
Save
E-mail